CIK 0002019410 · Non-accelerated filer<br>Emerging growth company
Caris Life Sciences, Inc.
Sign in to watch- Ticker
- CAI
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- TX
- Entity type
- operating
- EIN
- 852077369
- Phone
- (866) 771-8946
- Business address
- 750 W JOHN CARPENTER FREEWAY, SUITE 800, IRVING, TX, 75039
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $27,204,813
- in 3 filings
Net −$27,204,813. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-03-25 | HALBERT DAVID D See Remarks | Grant or award | +360,750 | 2,023,250 | ||
| 2025-03-03 | Spetzler David Baxley President | Returned to the company | −700,509 | $18.60 | $13.0M | 351,240 |
| 2025-03-03 | Spetzler David Baxley President | Grant or award · Stock Option | +750,000 | 750,000 | ||
| 2025-03-03 | Denton John Russel See Remarks | Returned to the company | −238,230 | $18.60 | $4.4M | 16,770 |
| 2025-03-03 | Denton John Russel See Remarks | Grant or award · Stock Option | +255,000 | 255,000 | ||
| 2025-02-27 | HALBERT JON Director | Grant or award | +16,129 | 116,129 | ||
| 2025-02-27 | CASTLEMAN PETER M Director | Grant or award | +16,129 | 16,129 | ||
| 2025-02-27 | CASTLEMAN PETER M Director | Grant or award · Stock Option | +2,500 | 2,500 |
Page 6 of 6 · 108 trades